Natixis Advisors, L.P. Conmed Corp Transaction History
Natixis Advisors, L.P.
- $51.3 Billion
- Q3 2024
A detailed history of Natixis Advisors, L.P. transactions in Conmed Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 110,909 shares of CNMD stock, worth $8.01 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
110,909
Previous 81,189
36.61%
Holding current value
$8.01 Million
Previous $5.63 Million
41.74%
% of portfolio
0.02%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding CNMD
# of Institutions
307Shares Held
33.7MCall Options Held
123KPut Options Held
24.2K-
Black Rock Inc. New York, NY4.99MShares$361 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.53MShares$255 Million0.0% of portfolio
-
Earnest Partners LLC Atlanta, GA2.78MShares$201 Million0.91% of portfolio
-
Capital Research Global Investors Los Angeles, CA1.54MShares$112 Million0.02% of portfolio
-
Bank Of America Corp Charlotte, NC1.37MShares$99 Million0.01% of portfolio
About CONMED Corp
- Ticker CNMD
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 30,482,400
- Market Cap $2.2B
- Description
- CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...